Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04124029 · ClinicalTrials.gov registry record
Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
A clinical trial of Mild Cognitive Impairment and Mild Traumatic Brain Injury, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- 800
- Enrollment target
- 1
- Study location
NCT04124029 is a study of Mild Cognitive Impairment and Mild Traumatic Brain Injury that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 800 participants, below the 1,267-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04124029, a study of Mild Cognitive Impairment and Mild Traumatic Brain Injury, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study that aims to examine whether Veterans with mild Traumatic Brain Injuries are at risk for dementia by studying their memory, brain wave activity, brain structure and proteins that can be elevated after brain injury and in dementia.
Conditions Studied
Interventions
- DEVICE No Intervention is used for this study but all subjects will be asked to complete EEG testing and an MRI scan.
- PROCEDURE No intervention is used for this study but all subjects will be asked to complete a venous blood draw procedure and a lumbar puncture procedure.
Study Locations (1)
Massachusetts
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04124029
The ClinicalTrials.gov registry entry for NCT04124029 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,267-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (37% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which No Intervention is used for this study but all subjects will be asked to complete EEG testing and an MRI scan. is the first listed.
NCT04124029 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04124029 about?
NCT04124029 is a clinical study titled "Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)". This is a research study that aims to examine whether Veterans with mild Traumatic Brain Injuries are at risk for dementia by studying their memory, brain wave activity, brain structure and proteins that can be elevated after brain injury and in dementia.
What is the current status of trial NCT04124029?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2021-07-01. Estimated completion is 2026-06-30.
What conditions does trial NCT04124029 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Mild Traumatic Brain Injury, Moderate Traumatic Brain Injury.
What interventions are being tested in trial NCT04124029?
The interventions under investigation include: No Intervention is used for this study but all subjects will be asked to complete EEG testing and an MRI scan. (DEVICE), No intervention is used for this study but all subjects will be asked to complete a venous blood draw procedure and a lumbar puncture procedure. (PROCEDURE).
Who is sponsoring clinical trial NCT04124029?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04124029 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
RECRUITING · Early Phase 1
-
MCI Speech in Noise
RECRUITING
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
RECRUITING
Explore more on PlainTrial
Mild Cognitive Impairment
All registered trials for this condition
Mild Traumatic Brain Injury
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.